N. Johnson

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
20250 citationsauthor #269
Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries
20250 citationsauthor #52
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women
20250 citationsauthor #53
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
20249 citationsauthor #72
Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction
20246 citationsauthor #72
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
20233 citationsauthor #71
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
20230 citationsauthor #60
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
20235 citationsauthor #186
Rare germline copy number variants (CNVs) and breast cancer risk
202211 citationsauthor #58
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
20217 citationsauthor #72
Rare copy number variants (CNVs) and breast cancer risk
20210 citationsauthor #61
Identifying high-confidence capture Hi-C interactions using CHiCANE
202115 citationsauthor #7
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
20218 citationsauthor #1
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
20217 citationsauthor #2
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
202039 citationsauthor #122
CYP3A7*1C allele linked to cancer mortality, progression
20200 citationsauthor #1
Abstract PD3-08: Assessment of the tumor immune environment in inflammatory breast cancer treated with neoadjuvant dual-HER2 blockade
20192 citationsauthor #5
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
2019114 citationsauthor #210
Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk
201924 citationsauthor #17
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
2019153 citationsauthor #390
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
2018208 citationsauthor #105
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
201896 citationsauthor #107
PO-054 Common genetic variants at the breast cancer risk region 2Q35 map to putative IGFbp5 enhancers
20180 citationsauthor #4
Capture Hi-C identifies putative target genes at 33 breast cancer risk loci
201897 citationsauthor #5
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
2018887 citationsauthor #119
Abstract 5316: DNA methylation index of lifetime estrogen exposure in breast cancer
20180 citationsauthor #17
Association analysis identifies 65 new breast cancer risk loci
20171,295 citationsauthor #157
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
2017361 citationsauthor #221
CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites
201714 citationsauthor #2
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
201674 citationsauthor #29
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
201681 citationsauthor #25
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
2016228 citationsauthor #55
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.
201690 citationsauthor #40
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
20160 citationsauthor #57
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus
201690 citationsauthor #269
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)
201627 citationsauthor #63
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
201631 citationsauthor #1
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
201620 citationsauthor #150
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
2016116 citationsauthor #64
PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS
2016173 citationsauthor #37
Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
201643 citationsauthor #61
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
201628 citationsauthor #60
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
2016100 citationsauthor #54
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
201615 citationsauthor #19
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
2015547 citationsauthor #23
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.
201516 citationsauthor #32
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
2015122 citationsauthor #41
Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk
201532 citationsauthor #57
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2
201550 citationsauthor #7
Fine-mapping identi fi es two additional breast cancer susceptibility loci at 9 q 31 . 2
20152 citationsauthor #7
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
201591 citationsauthor #33
Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22
20150 citationsauthor #57
Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study
20144 citationsauthor #1
MicroRNA Related Polymorphisms and Breast Cancer Risk
2014560 citationsauthor #24
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
20144 citationsauthor #55
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository
20141 citationsauthor #27
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
201430 citationsauthor #1
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
2014114 citationsauthor #122
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
201434 citationsauthor #55
Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C
2014238 citationsauthor #4
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
201468 citationsauthor #65
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
20141 citationsauthor #1
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
201424 citationsauthor #103
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.
201445 citationsauthor #103
Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions
201435 citationsauthor #53
Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk
20149 citationsauthor #25
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
201453 citationsauthor #15
susceptibility loci by Capture HiC Unbiased analysis of potential targets of breast cancer
20140 citationsauthor #3
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.
201415 citationsauthor #116
Abstract P4-05-10: PIK3CA mutations are enriched in invasive lobular carcinomas and invasive mammary carcinomas with lobular features: Results from a TCGA sub-analysis
20130 citationsauthor #5
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
2013435 citationsauthor #78
Abstract P4-05-06: Host inflammation and breast cancer molecular subtypes: Updated results from a TCGA sub-analysis
20130 citationsauthor #7
Abstract P4-05-15: Breast cancers with BRCA1 and BRCA2 mutations are associated with specific pathologic features and molecular profiles: Results from a TCGA sub-analysis
20130 citationsauthor #8
A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
201321 citationsauthor #21
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
2013120 citationsauthor #31
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
20131,124 citationsauthor #73
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
2013236 citationsauthor #51
Common Breast Cancer Susceptibility Variants in LSP1 and RAD51L1 Are Associated with Mammographic Density Measures that Predict Breast Cancer Risk
2012112 citationsauthor #50
Association of rs12662670 with breast cancer in Asian ER
20120 citationsauthor #20
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers.
20120 citationsauthor #35
Genome-wide association analysis identifies three new breast cancer susceptibility loci
2012304 citationsauthor #16
11q13 is a susceptibility locus for hormone receptor positive breast cancer
201241 citationsauthor #90
Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
20124 citationsauthor #20
Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
201259 citationsauthor #22
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium
201223 citationsauthor #5
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
201233 citationsauthor #1
Cancer Using Marker Data from Bilateral and Familial Cases Estimating Causal Effects of Genetic Risk Variants for Breast
20120 citationsauthor #4
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2
201214 citationsauthor #35
Genome-wide association study identifies a novel variant in RAD51B associated with male breast cancer risk
201269 citationsauthor #7
Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2
20120 citationsauthor #37
Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus
20120 citationsauthor #61
CYP 3 A Variation , Premenopausal Estrone Levels , and Breast Cancer Risk
20123 citationsauthor #1
19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
2012120 citationsauthor #62
Estimating Causal Effects of Genetic Risk Variants for Breast Cancer Using Marker Data from Bilateral and Familial Cases
20116 citationsauthor #4
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
2011267 citationsauthor #2
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
201192 citationsauthor #20
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls
201041 citationsauthor #2
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
2010106 citationsauthor #13
Authors and Disclosures
20100 citationsauthor #1
sense Variants in ATM in 26 , 101 Breast Cancer B & P es and 29 , 842 Controls
20100 citationsauthor #13

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT